论文部分内容阅读
血小板增多症与恶性肿瘤相关联。近年来,有人研究发现此症是影响小细胞肺癌的重要因素。基于上述观点,作者分析1988～1992年间643例宫颈癌患者的5年生存率。血小板≥400×10~9/L为血小板增高症。作者分别考察病人的年龄、组织学类型、临床分期、淋巴结转移情况与合并此症对病人生存率的影响。 肿瘤合并血小板增多症者5年生存率为57.1％,未合并者76.5％;有统计学差异(P<0.01);平均发病年龄与此症无差异;合并此症者78％为鳞癌,9.2％为腺癌,5年生存率鳞癌
Thrombocytosis is associated with malignancy. In recent years, some studies have found that this disease is an important factor affecting small cell lung cancer. Based on the above viewpoints, the authors analyzed the 5-year survival rate of 643 cervical cancer patients from 1988 to 1992. Platelets ≥ 400 × 10 ~ 9 / L for thrombocytosis. The authors examined the patient’s age, histological type, clinical stage, lymph node metastasis and the impact of combined disease on patient survival. The 5-year survival rate was 57.1% in patients with tumor complicated with thrombocytopenia and 76.5% in patients with non-combined thrombocytopenia (P <0.01). There was no difference in the average age of onset between the two groups. 78% % Of adenocarcinoma, 5-year survival rate of squamous cell carcinoma